10 medical trials to watch in the first 50 % of 2025 Predicted readouts in diabetes, cancer and despair headline a series of study benefits that may assist the biotechnology sector regain its footing after a shaky year.Although ACP values efforts to eliminate barriers to care, which is among Lilly’s mentioned plans, “they ought to not devalue t